KHALED QAISIEH: Open Payments
NPI 1750842100 · BROUSSARD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 24 payments from 7 companies in 2025. Trend: 2023 $36 · 2024 $172 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 10 | $305 |
| Insulet Corporation | 2 | $204 |
| BETA BIONICS, INC. | 3 | $199 |
| Medtronic, Inc. | 2 | $126 |
| Tandem Diabetes Care, Inc. | 5 | $117 |
| Novo Nordisk Inc | 1 | $104 |
| Amgen Inc. | 1 | $95 |
Products named: Dexcom G6 Transmitter, Omnipod, iLet Bionic Pancreas, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Ozempic, EVENITY.
Industry payments across LA — which companies pay providers there.
